<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://articlefeeds.nasdaq.com/~d/styles/itemcontent.css"?><rss xmlns:a10="http://www.w3.org/2005/Atom" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
  <channel xmlns:nasdaq="http://nasdaq.com/reference/feeds/1.0/">
    <title>Latest Articles about STXS</title>
    <description />
    <language>EN-US</language>
    <lastBuildDate>Mon, 20 May 2013 17:58:44 -0400</lastBuildDate>
    <atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://articlefeeds.nasdaq.com/nasdaq/symbols?symbol=STXS" /><feedburner:info uri="nasdaq/symbols" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><item xml:base="http://www.nasdaq.com/article/hansen-medical-boosts-ip-portfolio-analyst-blog-cm166978">
      <guid isPermaLink="false">166978</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/svqaCpkbSBY/hansen-medical-boosts-ip-portfolio-analyst-blog-cm166978</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Hansen Medical Boosts IP Portfolio  - Analyst Blog</title>
      <description>Hansen Medical  (  HNSN  ), a global developer and manufacturer of intravascular robotics, recently announced the expansion of its intellectual property portfolio on the back of 30 additional&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/svqaCpkbSBY" height="1" width="1"/&gt;</description>
      <pubDate>Sat, 25 Aug 2012 00:32:49 Z</pubDate>
      <a10:updated>2012-08-24T21:34:51Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>BSX</nasdaq:tickers>
      <nasdaq:tickers>HNSN</nasdaq:tickers>
      <nasdaq:tickers>JNJ</nasdaq:tickers>
      <nasdaq:tickers>STXS</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/hansen-medical-boosts-ip-portfolio-analyst-blog-cm166978</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/fda-clears-hansens-robotic-system-analyst-blog-cm146340">
      <guid isPermaLink="false">146340</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/P7Bu_A2P4eQ/fda-clears-hansens-robotic-system-analyst-blog-cm146340</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>FDA Clears Hansen's Robotic System - Analyst Blog</title>
      <description>On June 4, 2012, global developer and manufacturer of robotics  Hansen Medical, Inc.  (  HNSN  ) announced the U.S. Food and Drug Association (FDA) 510(k) clearance for its Magellan Robotic&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/P7Bu_A2P4eQ" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 06 Jun 2012 02:46:01 Z</pubDate>
      <a10:updated>2012-06-05T23:52:52Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>BSX</nasdaq:tickers>
      <nasdaq:tickers>HNSN</nasdaq:tickers>
      <nasdaq:tickers>JNJ</nasdaq:tickers>
      <nasdaq:tickers>STXS</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/fda-clears-hansens-robotic-system-analyst-blog-cm146340</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/weekly-cfo-buys-highlight-nbn-emms-stxs-foe-nvtl-cm142852">
      <guid isPermaLink="false">142852</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RyVU0uoc_y4/weekly-cfo-buys-highlight-nbn-emms-stxs-foe-nvtl-cm142852</link>
      <category>Investing</category>
      <title>Weekly CFO Buys Highlight: NBN, EMMS, STXS, FOE, NVTL</title>
      <description>According to        GuruFocus Insider Data     , these are the largest CFO buys during the past week. The   overall trend of CFOs is illustrated in the chart below:&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/RyVU0uoc_y4" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 21 May 2012 19:40:54 Z</pubDate>
      <a10:updated>2012-05-21T16:41:24Z</a10:updated>
      <author>gurujk</author>
      <nasdaq:tickers>EMMS</nasdaq:tickers>
      <nasdaq:tickers>FOE</nasdaq:tickers>
      <nasdaq:tickers>NBN</nasdaq:tickers>
      <nasdaq:tickers>NVTL</nasdaq:tickers>
      <nasdaq:tickers>STXS</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/weekly-cfo-buys-highlight-nbn-emms-stxs-foe-nvtl-cm142852</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/stereotaxis-beats-loss-widens-analyst-blog-cm125567">
      <guid isPermaLink="false">125567</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LcFVNDRf488/stereotaxis-beats-loss-widens-analyst-blog-cm125567</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Stereotaxis Beats, Loss Widens - Analyst Blog</title>
      <description>Medical equipment maker   Stereotaxis Inc   's (   STXS   ) fourth-quarter fiscal 2011 loss per share of 10 cents was lower than the Zacks Consensus Estimate of a loss of 14 cents and above the&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/LcFVNDRf488" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 07 Mar 2012 18:30:01 Z</pubDate>
      <a10:updated>2012-03-07T15:08:27Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>BSX</nasdaq:tickers>
      <nasdaq:tickers>EW</nasdaq:tickers>
      <nasdaq:tickers>STXS</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/stereotaxis-beats-loss-widens-analyst-blog-cm125567</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/milestone-for-stereotaxis-vdrive-analyst-blog-cm120757">
      <guid isPermaLink="false">120757</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8lDvvYo3iIc/milestone-for-stereotaxis-vdrive-analyst-blog-cm120757</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Milestone for Stereotaxis Vdrive - Analyst Blog</title>
      <description>Medical equipment maker   Stereotaxis Inc.   (   STXS   ) has reported adoption milestone for its Vdrive robotic navigation system in Europe. The company said that the device is gaining&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/8lDvvYo3iIc" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 15 Feb 2012 01:00:01 Z</pubDate>
      <a10:updated>2012-02-14T22:07:55Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>BSX</nasdaq:tickers>
      <nasdaq:tickers>EW</nasdaq:tickers>
      <nasdaq:tickers>STXS</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/milestone-for-stereotaxis-vdrive-analyst-blog-cm120757</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/milestone-for-stereotaxis-niobe-es-analyst-blog-cm114739">
      <guid isPermaLink="false">114739</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ec3SjYiNd_k/milestone-for-stereotaxis-niobe-es-analyst-blog-cm114739</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Milestone for Stereotaxis' Niobe ES - Analyst Blog</title>
      <description>Medical equipment maker   Stereotaxis Inc.   (   STXS   ) reported encouraging results from its recently completed first 50 clinical procedures performed using its new Niobe ES system for&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/Ec3SjYiNd_k" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 17 Jan 2012 21:45:01 Z</pubDate>
      <a10:updated>2012-01-17T18:45:30Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>BSX</nasdaq:tickers>
      <nasdaq:tickers>EW</nasdaq:tickers>
      <nasdaq:tickers>STXS</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/milestone-for-stereotaxis-niobe-es-analyst-blog-cm114739</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/stereotaxis-begins-epoch-shipment-analyst-blog-cm109443">
      <guid isPermaLink="false">109443</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Zp2Z8D5Xgqs/stereotaxis-begins-epoch-shipment-analyst-blog-cm109443</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Stereotaxis Begins Epoch Shipment - Analyst Blog</title>
      <description>Medical equipment maker   Stereotaxis Inc   (   STXS   ) has commenced initial shipments of its new Epoch platform designed for the electrophysiology ("EP") labs.&amp;#160; Launched&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/Zp2Z8D5Xgqs" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 16 Dec 2011 21:45:01 Z</pubDate>
      <a10:updated>2011-12-16T18:02:59Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>BSX</nasdaq:tickers>
      <nasdaq:tickers>EW</nasdaq:tickers>
      <nasdaq:tickers>STXS</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/stereotaxis-begins-epoch-shipment-analyst-blog-cm109443</feedburner:origLink></item>
  </channel>
</rss>
